Overview

Comparative Bioavailability Study of UDCA

Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate bioavailability of two formulations of ursodiol.
Phase:
Phase 1
Details
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.
Treatments:
Ursodeoxycholic Acid